Cincinnati, OH, United States of America

Esa T Jarvi

This inventor holds 8 USPTO granted patents, plus 9 CIPO patents and 1 EPO patent. Top assignees: Merrell Dow Pharmaceuticals, Merrell Pharmaceuticals, Inc., Other. Active years: 1991-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Esa T Jarvi. Retrieved from https://idiyas.com/inventor/esa-t-jarvi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 


Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 1991-1999

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Esa T. Jarvi: Innovator at Specgx LLC

Introduction

Esa T. Jarvi is a notable professional based in the United States, currently contributing his expertise to Specgx LLC. Despite being an influential figure in his field, he has yet to secure any patents.

Latest Patents

At this time, Esa T. Jarvi does not hold any patents. His current work and ideas may still be under development, potentially leading to future innovations.

Career Highlights

Esa has been an integral part of Specgx LLC, where he applies his skills and knowledge to advance the company's mission. His work contributes to the innovative landscape of the industry, although specific milestones in terms of patents are yet to be achieved.

Collaborations

Esa has collaborated with talented individuals such as Brenda E. Allen and Dennis J. Kalota at Specgx LLC. These partnerships foster a creative environment conducive to innovation and the development of new concepts.

Conclusion

Esa T. Jarvi’s journey at Specgx LLC highlights his commitment to innovation in the industry. While he currently does not hold any patents, his collaborative efforts and dedication to his work suggest a bright future in the realm of inventions and advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…